Selected Recent Publications from Ganesh Laboratory
- Banik A, Amaradhi R, Sau M, Rawat V, Dingledine R, Ganesh T. Antagonism of the EP2 Receptor Reveals Sex-Specific Protection in a Two-Hit Mouse Model of Alzheimer's Disease. ACS Chem Neurosci. 2026;17(2):392-403. PubMed PMID: 41481312; PMCID: PMC12828713.
- Ganesh T. Targeting EP2 Receptor for Drug Discovery: Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis. J Med Chem. 2023;66(14):9313-24. PubMed PMID: 37458373; PMCID: PMC10388357.
- Ganesh T, Pourkhodadad S, Heman-Bozadas P, Dingledine R, Wang W, Rawat V, Varvel NH, Herr RJ, Jiang Q, Johnson G. Novel EP2 Antagonist Attenuates Microgliosis and Memory Deficits in Pilocarpine-Induced Status Epilepticus Mice. J Med Chem. 2026. PubMed PMID: 41985077.
- Juric M, Rawat V, Amaradhi R, Zielonka J, Ganesh T. Novel NADPH Oxidase-2 Inhibitors as Potential Anti-Inflammatory and Neuroprotective Agents. Antioxidants (Basel). 2023;12(9). PubMed PMID: 37759963; PMCID: PMC10525516.
- Varvel NH, Amaradhi R, Espinosa-Garcia C, Duddy S, Franklin R, Banik A, Aleman-Ruiz C, Blackmer-Raynolds L, Wang W, Honore T, Ganesh T, Dingledine R. Preclinical development of an EP2 antagonist for post-seizure cognitive deficits. Neuropharmacology. 2023;224:109356. PubMed PMID: 36460083; PMCID: PMC9894535.